These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 15817343

  • 1. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia.
    Ringash J, Warde P, Lockwood G, O'Sullivan B, Waldron J, Cummings B.
    Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1403-7. PubMed ID: 15817343
    [Abstract] [Full Text] [Related]

  • 2. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
    Jabbari S, Kim HM, Feng M, Lin A, Tsien C, Elshaikh M, Terrel JE, Murdoch-Kinch C, Eisbruch A.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):725-31. PubMed ID: 16199308
    [Abstract] [Full Text] [Related]

  • 3. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
    Scarantino C, LeVeque F, Swann RS, White R, Schulsinger A, Hodson DI, Meredith R, Foote R, Brachman D, Lee N.
    J Support Oncol; 2006 May 01; 4(5):252-8. PubMed ID: 16724649
    [Abstract] [Full Text] [Related]

  • 4. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy.
    Scrimger R, Kanji A, Parliament M, Warkentin H, Field C, Jha N, Hanson J.
    Am J Clin Oncol; 2007 Jun 01; 30(3):271-7. PubMed ID: 17551304
    [Abstract] [Full Text] [Related]

  • 5. Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer.
    Jellema AP, Slotman BJ, Doornaert P, Leemans CR, Langendijk JA.
    Int J Radiat Oncol Biol Phys; 2007 Nov 01; 69(3):751-60. PubMed ID: 17560735
    [Abstract] [Full Text] [Related]

  • 6. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
    Burlage FR, Roesink JM, Kampinga HH, Coppes RP, Terhaard C, Langendijk JA, van Luijk P, Stokman MA, Vissink A.
    Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):14-22. PubMed ID: 17869018
    [Abstract] [Full Text] [Related]

  • 7. Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.
    Duncan GG, Epstein JB, Tu D, El Sayed S, Bezjak A, Ottaway J, Pater J, National Cancer Institute of Canada Clinical Trials Group.
    Head Neck; 2005 May 01; 27(5):421-8. PubMed ID: 15782422
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: A prospective randomized study in squamous cell head and neck cancer.
    Jellema AP, Slotman BJ, Muller MJ, Leemans CR, Smeele LE, Hoekman K, Aaronson NK, Langendijk JA.
    Cancer; 2006 Aug 01; 107(3):544-53. PubMed ID: 16804929
    [Abstract] [Full Text] [Related]

  • 10. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia.
    Jha N, Seikaly H, Harris J, Williams D, Sultanem K, Hier M, Ghosh S, Black M, Butler J, Sutherland D, Kerr P, Barnaby P.
    Head Neck; 2009 Feb 01; 31(2):234-43. PubMed ID: 19107948
    [Abstract] [Full Text] [Related]

  • 11. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
    Sangthawan D, Watthanaarpornchai S, Phungrassami T.
    J Med Assoc Thai; 2001 Feb 01; 84(2):195-203. PubMed ID: 11336078
    [Abstract] [Full Text] [Related]

  • 12. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA.
    Int J Radiat Oncol Biol Phys; 2009 May 01; 74(1):1-8. PubMed ID: 19111400
    [Abstract] [Full Text] [Related]

  • 13. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy.
    Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo ME.
    Head Neck; 2005 Aug 01; 27(8):659-68. PubMed ID: 15920748
    [Abstract] [Full Text] [Related]

  • 14. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
    Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, Leung WK.
    Int J Radiat Oncol Biol Phys; 2006 Nov 15; 66(4):981-91. PubMed ID: 17145528
    [Abstract] [Full Text] [Related]

  • 15. Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy.
    Braam PM, Roesink JM, Raaijmakers CP, Busschers WB, Terhaard CH.
    Radiat Oncol; 2007 Jan 05; 2():3. PubMed ID: 17207274
    [Abstract] [Full Text] [Related]

  • 16. Assessment of xerostomia and its impact on quality of life in head and neck cancer patients undergoing radiotherapy, and validation of the Taiwanese version of the xerostomia questionnaire.
    Lin SC, Jen YM, Chang YC, Lin CC.
    J Pain Symptom Manage; 2008 Aug 05; 36(2):141-8. PubMed ID: 18395402
    [Abstract] [Full Text] [Related]

  • 17. Preventing radiation induced xerostomia.
    Koukourakis MI, Danielidis V.
    Cancer Treat Rev; 2005 Nov 05; 31(7):546-54. PubMed ID: 16257125
    [Abstract] [Full Text] [Related]

  • 18. Acupuncture for radiation-induced xerostomia in patients with cancer: a pilot study.
    Garcia MK, Chiang JS, Cohen L, Liu M, Palmer JL, Rosenthal DI, Wei Q, Tung S, Wang C, Rahlfs T, Chambers MS.
    Head Neck; 2009 Oct 05; 31(10):1360-8. PubMed ID: 19378325
    [Abstract] [Full Text] [Related]

  • 19. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy.
    Fang FM, Liu YT, Tang Y, Wang CJ, Ko SF.
    Cancer; 2004 Jan 15; 100(2):425-32. PubMed ID: 14716781
    [Abstract] [Full Text] [Related]

  • 20. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI, Chao KS, El Naqa I, Franklin GE, Zakarian K, Vicic M, Deasy JO.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1055-69. PubMed ID: 15990009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.